Search
forResearch 5 of 14
- Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Unusual progression of renal cell carcinoma with carcinomatosis peritoneii and Krukenberg tumour and alopecia with sunitinib therapy in young female
- Effets secondaires cutanéo-muqueux des nouvelles molécules anticancéreuses: Inhibiteurs de l'EGF-R, inhibiteurs de tyrosine kinase et stabilisateurs du fuseau mitotique
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →